Breast Cancer Res. 2007;9(5):112.

Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer.

Source

Department of Medicine, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK. Alexandra.leary@icr.ac.uk

Abstract

A greater understanding of the biological mechanisms responsible for de novo and acquired endocrine resistance has led to the rational design of clinical trials exploring the benefit of combining hormonal therapies with novel biological agents in an effort to enhance the efficacy of ER+ breast cancer treatment. These studies are increasingly including parallel biological analyses to elucidate the molecular characteristics of those tumors that are most likely to respond to specific targeted/endocrine combinations in an effort to develop a tailored approach to the management of individual patients. Unfortunately despite encouraging preclinical data, some of these combinations have yielded disappointing results in the clinical setting. This article will review the results of clinical trials of endocrine/biological combinations conducted in early and advanced breast cancer as well as provide an update on ongoing studies.

PMID:: 17980056; [PubMed - indexed for MEDLINE]
PMCID:: PMC2242654

Free PMC Article

Publication Types, MeSH Terms, Substances

Publication Types

Editorial

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Endocrine therapy and other targeted therapies for metastatic breast cancer. [Expert Rev Anticancer Ther. 2004]
Review Endocrine therapy and other targeted therapies for metastatic breast cancer.
Hussain SA, Palmer DH, Moon S, Rea DW. Expert Rev Anticancer Ther. 2004 Dec; 4(6):1179-95.
Review Aromatase inhibitors: combinations with fulvestrant or signal transduction inhibitors as a strategy to overcome endocrine resistance. [J Steroid Biochem Mol Biol. 2005]
Review Aromatase inhibitors: combinations with fulvestrant or signal transduction inhibitors as a strategy to overcome endocrine resistance.
Johnston SR, Martin LA, Head J, Smith I, Dowsett M. J Steroid Biochem Mol Biol. 2005 May; 95(1-5):173-81.
Review Overview of resistance to systemic therapy in patients with breast cancer. [Adv Exp Med Biol. 2007]
Review Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Adv Exp Med Biol. 2007; 608:1-22.
Review Clinical trials of intracellular signal transductions inhibitors for breast cancer--a strategy to overcome endocrine resistance. [Endocr Relat Cancer. 2005]
Review Clinical trials of intracellular signal transductions inhibitors for breast cancer--a strategy to overcome endocrine resistance.
Johnston SR. Endocr Relat Cancer. 2005 Jul; 12 Suppl 1:S145-57.
Enhancing endocrine response with novel targeted therapies: why have the clinical trials to date failed to deliver on the preclinical promise? [Cancer. 2008]
Enhancing endocrine response with novel targeted therapies: why have the clinical trials to date failed to deliver on the preclinical promise?
Johnston SR, Leary A, Martin LA, Smith IE, Dowsett M. Cancer. 2008 Feb 1; 112(3 Suppl):710-7.

See reviews... See all...

Cited by 3 PubMed Central articles

Complex prolactin crosstalk in breast cancer: new therapeutic implications. [Mol Cell Endocrinol. 2009]
Complex prolactin crosstalk in breast cancer: new therapeutic implications.
Carver KC, Arendt LM, Schuler LA. Mol Cell Endocrinol. 2009 Aug 13; 307(1-2):1-7. Epub 2009 Apr 1.
Review Molecular targeted therapies for breast cancer treatment. [Breast Cancer Res. 2008]
Review Molecular targeted therapies for breast cancer treatment.
Schlotter CM, Vogt U, Allgayer H, Brandt B. Breast Cancer Res. 2008; 10(4):211. Epub 2008 Jul 24.
Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer. [Br J Cancer. 2008]
Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer.
Appels NM, Bolijn MJ, Chan K, Stephens TC, Hoctin-Boes G, Middleton M, Beijnen JH, de Bono JS, Harris AL, Schellens JH. Br J Cancer. 2008 Jun 17; 98(12):1951-8. Epub 2008 May 27.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Clinical trials update: endocrine and biological therapy combinations in the tre...
Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer.
Breast Cancer Res. 2007 ;9(5):112.

PubMed
Shaping the future of interactome networks.
Shaping the future of interactome networks.
Genome Biol. 2007 ;8(10):316.

PubMed
Acupuncture in the treatment of rheumatoid arthritis: a double-blind controlled ...
Acupuncture in the treatment of rheumatoid arthritis: a double-blind controlled pilot study.
BMC Complement Altern Med. 2007 Nov 3 ;7:35.

PubMed
Extracting gene expression patterns and identifying co-expressed genes from micr...
Extracting gene expression patterns and identifying co-expressed genes from microarray data reveals biologically responsive processes.
BMC Bioinformatics. 2007 Nov 2 ;8:427.

PubMed
Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stre...
Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress.
Clin Endocrinol (Oxf). 2008 May ;68(5):806-13. Epub 2007 Nov 2 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: